Tabid, Cyruz .

HRN: 22-63-05  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2025
CEFUROXIME 750MG (VIAL)
01/10/2025
01/17/2025
INTRAVENOUS
330 Mg
Every 8 Hours
PCAP-C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: